Arkansas Contract Court Statute 
SCOTUSBlog
JANUARY 16, 2025
Share The Relist Watch column examines cert petitions that the Supreme Court has relisted for its upcoming conference. The Supreme Courts upcoming conference the second January conference — is ordinarily the justices last opportunity to add new cases to the docket in time for them to review and decide the disputes by the summer recess.
Above The Law
APRIL 7, 2025
(Photo by Samuel Corum/Getty Images) Supreme Court Justice Amy Coney Barrett, once celebrated as a stalwart conservative and a crowning achievement of the Trump presidency, now finds herself under fire from the very base that championed her confirmation. Her recent vote in Department of State v. Lets unpack the data.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Above The Law
JULY 7, 2025
I submitted comments in response to the Supreme Court of Texas’s order requesting input about whether to maintain ABA accreditation for Texas law schools or pursue alternatives. Read more here (gift link). The Cowboy Carter Tour, Northwest Stadium (photos by Renee Jefferson) It was a busy week leading up to the holiday. We Can Stop It.”
FDA Law
MARCH 24, 2024
By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. Code Ann. § 23-92-604(c)(1), (2) (Act 1103).
SCOTUSBlog
DECEMBER 13, 2020
The Supreme Court’s opinion Thursday in Rutledge v. Pharmaceutical Care Management Association firmly rejected an attack on state statutes that protect pharmacies from the prescription-reimbursement intermediaries that health-insurance providers use to administer their prescription-drug programs.
FDA Law
MAY 30, 2024
Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. By Sophia R. Gaulkin & Alan M.
FDA Law
OCTOBER 6, 2021
By Faraz Siddiqui — Last week, we blogged about a growing list of drug manufacturers that have refused to follow a 2010 guidance issued by the Health Resources and Services Administration (“HRSA”), which permits 340B covered entities to contract with multiple pharmacies to dispense drugs to covered entity patients. Code Ann. § Code Ann.§
Expert insights. Personalized for you.
103 
Let's personalize your content